Skip to main content

Table 5 Adjusted Odds Ratios (95% CI) of SCCHN for the p73 exon 2 G4A- p53 interaction analysis.

From: A case-control study on the combined effects of p53 and p73 polymorphisms on head and neck cancer risk in an Italian population

  

p53 intron 3 (rs1788332)

p53 intron 6 (rs1625895)

p53 exon4 Arg72Pro (rs1042522)

  

wt/wt

mt carriers

wt/wt

mt carriers

wt/wt

mt carriers

 

wt/wt

1*

1.05 (0.57–1.91)

1*

0.94 (0.53–1.68)

1*

0.92 (0.53–1.61)

 

cases/controls

136/152

51/62

137/140

50/74

129/124

58/90

p73 exon 2 G4A

mt carriers

1.25 (0.70–2.25)

2.22 (1.08–4.56)

1.49 (0.82–2.70)

1.50 (0.75–3.02)

1.33 (0.69–2.55)

1.63 (0.86–3.11)

(rs1801173/rs2273953)

cases/controls

56/56

40/24

57/51

39/29

45/44

51/36

  

p for interaction† = 0.30

p for interaction† = 0.89

p for interaction† = 0.55

  1. * = Reference category
  2. † = By likelihood ratio test